Press

VCs, Biotechs Spar

Scope of tax program is at issue in legislature
by Steve Berberich, Maryland Gazette Staff Writer, Friday, March 9, 2007

A legislative battle is brewing over proposed changes to the $6 million biotech tax credit law adopted last year.

Legislators next week will consider many changes in the program designed to entice more venture capital firms to take advantage of it.

Jonathan Cohen, president and CEO of 20/20 GeneSystems Inc. of Rockville, has retained lobbyist David Carroll of Capitol Strategies LLC to help keep the biotech tax credit at least at the same level of success...read more

 

Stem cell research gets a boost

State Senate leader says bill has chance
Maryland Gazette, Thursday, August 18, 2005

ANNAPOLIS — Senate President Thomas V. Mike Miller Jr. has added momentum to the push for embryonic stem cell research, saying the issue “absolutely“ has a chance to pass the Senate in next year's legislative session.

His comments boost a newly formed coalition that is planning an all-out campaign to get publicly funded embryonic stem cell research approved in the General Assembly next year...read more

 

Rising stars on inside track

New class of hired guns strides State House halls
by Alan Brody | Staff Writer | Friday, Jan. 9, 2009

The four-person lobbying shop of Capitol Strategies LLC has established itself as a player since its founding about 10 years ago. No stranger to the Maryland political scene, Sushant Sidh boasts a strong policy background in the Glendening administration and has campaign experience to boot.

Sidh, 35, who also worked with former Anne Arundel County Executive Janet S. Owens, counts Erickson Retirement Communities, Verizon and Washington Gas among his clients.